Search MedEsthetics: Page 31

3,002 Results
Section: News
Accure Acne announced its FDA clearance for its Accure Laser System to treat mild to severe inflammatory acne vulgaris.
FDA Clears the Accure Laser System for the Treatment of Acne Vulgaris
This technology advancement was accomplished through a unique pulsing algorithm, integrated temperature monitoring and precise control of the laser.
Dec 12th, 2022
[Treatment Release] The One-Hour Incisionless Facelift
The One-Hour Incisionless Facelift Uses the Power of Regenerative Medicine with Stem Cell/Exosome and Coolaser Technology
The 60 minute facelift that incorporates its patented Coolaser technology and stem cell/exosome technology. The procedure is based in regenerative medicine and is normally followed by one week of downtime.
Dec 12th, 2022
Epigenetic Aging Was the Hot Topic at the Academy of Anti-Aging Medicine's 30th Annual Longevity Fest
Epigenetic Aging Was the Hot Topic at the Academy of Anti-Aging Medicine's 30th Annual Longevity Fest
This year's program included several presentations on epigenetic aging, which has become a hot topic in many longevity spaces.
Dec 12th, 2022
Cosmetic Physician Partners (CPP) Launches Network of Physician-led Clinics
Cosmetic Physician Partners Launches Network of Physician-led Clinics, Providing Practitioner Alternatives to Private Equity
Led by Dr. A. Jay Burns, Dr. Joel L. Cohen, Matt and Kathy Taranto and Dan Schacter, CPP is a partnership designed to provide physician owners with an alternative to private equity.
Dec 12th, 2022
ELEVAI Expands Advisory Board with James R. Headley
Cosmetic Industry Veteran James R. Headley Brings His Considerable Business Expertise to ELEVAI's Advisory Board
Headley was previously the CEO of ZO Skin Health, and will now play an active role in supporting the ELEVAI management team as it evaluates strategic growth initiatives, product launches and brand partnerships.
Dec 9th, 2022
Yuyu Pharma Announces Plans to Enter the U.S. and European Markets for Hair Loss Treatment
Yuyu Pharma Plans to Introduce Korean Innovations in Hair Loss Treatments to the U.S. and European Markets
DUT was created to improve the patient experience by creating a tablet smaller in size, while keeping the exact same dosage of 0.5 mg.
Dec 9th, 2022
DefenAge Announces Defensin Anti-Aging Patent for Signature Cell Stimulating Technology
DefenAge Announces Defensin Anti-Aging Patent for Signature Cell Stimulating Technology
Developed for the last seven years, the patent recognizes DefenAge's cell stimulating compositions and methods to create fresh, new skin.
Dec 8th, 2022
LifeSprout's Dermal Filler Achieves Primary Endpoint in Clinical Trial
LifeSprout's Regenerative Matrix Technology Could Make Lumina a Class-Defining Dermal Filler
LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, announced positive six-month interim results from its clinical trial of Lumina, a dermal filler.
Dec 8th, 2022
GATTONI Medical Aesthetics & Wellness Open Medical Spa In Denver
GATTONI Medical Aesthetics & Wellness Opens Medical Spa In Denver
The clinic has mastered the art and science of anti-aging and regenerative medicine to deliver various services that enhance health and beauty, including: Botox, Dysport, Filler, Kybella, Sculptra, PRX-T33 Treatment and women's intimate health.
Dec 7th, 2022
CollPlant Expands Bioink Platform with Launch of Collink.3D 90
Regenerative Breast Implants Could Soon Be a Reality as CollPlant Launches a Second BioInk, Collink.3D 90
Collink.3D 90 is complementary to CollPlant's first commercial bioink, Collink.3D 50, which was launched late 2021, offering increased mechanical properties to address additional printing requirements of soft and hard tissues.
Dec 7th, 2022
An advanced fat transfer technique developed by Bill Johnson, M.D., offers the option of safer, more natural breast enhancements and brazilian butt lifts.
10 Factors to Discuss with Patients Considering a Breast Enhancement or BBL
An advanced fat transfer technique offers the option of safer, more natural breast enhancements and brazilian butt lifts. Here are the 10 most important factors to discuss with patients considering these serious procedures.
Dec 5th, 2022
Brexogen's BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
Brexogen's 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
It is the first phase one clinical trial of therapeutic exosome for atopic dermatitis in major countries. This IND clearance means patients with atopic dermatitis can benefit from receiving better treatment with 'BRE-AD01.'
Dec 5th, 2022
APX Platform Co-CEOs Terri Ross and Izhak Musli will be providing a full day of educational workshops on Dec. 10th at the 2022 Florida Plastic Surgery Forum.
APX Platform Co-CEOs Featured Presenters at 2022 Florida Plastic Surgery Forum
APX Platform Co-CEOs Terri Ross and Izhak Musli will be providing a full day of educational workshops on Dec. 10th at the 2022 Florida Plastic Surgery Forum.
Dec 2nd, 2022
The study examines the systemic symptoms self-reported by some breast implant patients, known as Breast Implant Illness.
Breast Implant Illness Biospecimen Study Results Revealed
The study examines the potential etiologies of the systemic symptoms self-reported by some breast implant patients known as Breast Implant Illness
Dec 2nd, 2022
iCRYO Adds Ozone UV IV Therapy & NAD+ Intramuscular Shots to Service Menu
iCRYO Adds Ozone UV IV Therapy & NAD+ Intramuscular Shots to Service Menu
iCRYO announced the additions of two new treatments to their core services: the Medical Ozone Ultraviolet Intravenous Therapy (Ozone UV IV Therapy) and NAD+ Intramuscular shots.
Dec 2nd, 2022
iCRYO to Attend The American Academy of Anti-Aging Medicine's Longevity Fest
iCRYO to Attend The American Academy of Anti-Aging Medicine's Longevity Fest
The year's Longevity Fest is celebrating 30 years of medical education innovation and will provide the latest knowledge targeting modern medical practice.
Dec 1st, 2022
female doctor using phone posting on social media
The Best Ways to Improve Your Brand's Instagram Engagement
The best time to make an impact is during the first 24 hours after posting, according to a study published in the November 2022 issue of Plastic and Reconstructive Surgery.
Nov 30th, 2022
Galderma will serve as the exclusive aesthetic injectables sponsor of the 21st annual art show.
Galderma & SCOPE Miami Beach 2022 Collaborate for Miami Art Week
The company will serve as the exclusive aesthetic injectables sponsor of the 21st annual art show.
Nov 30th, 2022
Previous Page
Page 31 of 167
Next Page